Endpoints for homocysteine-lowering trials
- PMID: 10682995
- DOI: 10.1016/S0140-6736(99)00437-7
Endpoints for homocysteine-lowering trials
Comment on
-
Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.Lancet. 2000 Feb 12;355(9203):517-22. doi: 10.1016/s0140-6736(99)07391-2. Lancet. 2000. PMID: 10683000 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical